Big Movers: Kinder Morgan, Inc. (NYSE:KMI), Verizon Communications Inc. (NYSE:VZ), ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), Flexion Therapeutics, Inc. (NASDAQ:FLXN)

Kinder Morgan Inc. (NYSE:KMI) announced plans to simplify its structure in August with a series of transactions to acquire associated pipeline limited partnerships for $44 billion. Kinder Morgan, Inc. (NYSE:KMI) in last trading activity fell -2.66% to close at $35.50. Company weekly performance is -8.32% while its quarterly performance stands at -1.85%. Kinder Morgan, Inc. (NYSE:KMI) is -16.45% away from its 52 week high.Verizon Communications Inc (NYSE:VZ) and AT&T INC (NYSE:T) are the top contenders in the wireless sector. Verizon Communications Inc (NYSE:VZ) bought 45 percent share of Vodaphone’s Wireless service for 130 billion dollars. That made Verizon Communications Inc (NYSE:VZ) the top wireless subscriber in the country. Below Verizon Communications Inc (NYSE:VZ)are companies like Sprint and T-Mobile which are nowhere near the hold exerted by Verizon Communications Inc (NYSE:VZ)on the wireless market.On last trading day Verizon Communications Inc. (NYSE:VZ) fell -1.16% to close at $48.37. Its volatility for the week is 1.41% while volatility for the month is 1.09%. VZ's sales growth for past 5 years was 4.40% and its EPS growth for past 5 years was 48.40%. Verizon Communications Inc. (NYSE:VZ) monthly performance is 1.07%.ZIOPHARM Oncology (NASDAQ:ZIOP) last issued its quarterly earnings data on Thursday, August 7th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.17) by $0.11. The company had revenue of $0.20 million for the quarter, compared to the consensus estimate of $7.50 million. During the same quarter in the previous year, the company posted ($0.22) earnings per share. The company’s revenue for the quarter was up .0% on a year-over-year basis. On average, analysts predict that ZIOPHARM Oncology will post $-0.42 earnings per share for the current fiscal year.On last trading day ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) advanced 0.82% to close at $2.45. Its volatility for the week is 6.31% while volatility for the month is 5.44%. ZIOP's EPS growth for past 5 years was 11.10%. ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) monthly performance is -23.91%.Shares of National Grid plc (NYSE:NGG) have earned a consensus recommendation of “Hold” from the fourteen ratings firms that are presently covering the stock. National Grid plc (NYSE:NGG) has its institutional ownership stands at 4.60%. In last trading activity company's stock closed at $69.76.The Food and Drug Administration, Flexion Therapeutics, Inc. (NASDAQ:FLXN) on Wednesday halted the midstage clinical trial of the company’s treatment of osteoarthritis of the knee. On Monday shares of Flexion Therapeutics, Inc. (NASDAQ:FLXN) closed at $15.41.